New insight in the relationship between regional patterns of knee cartilage thickness, osteoarthritis disease severity, and gait mechanics

2015 ◽  
Vol 48 (14) ◽  
pp. 3868-3875 ◽  
Author(s):  
Jennifer C. Erhart-Hledik ◽  
Julien Favre ◽  
Thomas P. Andriacchi
2021 ◽  
Vol 7 ◽  
Author(s):  
Liping Si ◽  
Kai Xuan ◽  
Jingyu Zhong ◽  
Jiayu Huo ◽  
Yue Xing ◽  
...  

Background: It was difficult to distinguish the cartilage thinning of an entire knee joint and to track the evolution of cartilage morphology alongside ages in the general population, which was of great significance for studying osteoarthritis until big imaging data and artificial intelligence are fused. The purposes of our study are (1) to explore the cartilage thickness in anatomical regions of the knee joint among a large collection of healthy knees, and (2) to investigate the relationship between the thinning pattern of the cartilages and the increasing ages.Methods: In this retrospective study, 2,481 healthy knees (subjects ranging from 15 to 64 years old, mean age: 35 ± 10 years) were recruited. With magnetic resonance images of knees acquired on a 3-T superconducting scanner, we automatically and precisely segmented the cartilage via deep learning and calculated the cartilage thickness in 14 anatomical regions. The thickness readings were compared using ANOVA by considering the factors of age, sex, and side. We further tracked the relationship between the thinning pattern of the cartilage thickness and the increasing ages by regression analysis.Results: The cartilage thickness was always thicker in the femur than corresponding regions in the tibia (p < 0.05). Regression analysis suggested cartilage thinning alongside ages in all regions (p < 0.05) except for medial and lateral anterior tibia in both females and males (p > 0.05). The thinning speed of men was faster than women in medial anterior and lateral anterior femur, yet slower in the medial patella (p < 0.05).Conclusion: We established the calculation method of cartilage thickness using big data and deep learning. We demonstrated that cartilage thickness differed across individual regions in the knee joint. Cartilage thinning alongside ages was identified, and the thinning pattern was consistent in the tibia while inconsistent in patellar and femoral between sexes. These findings provide a potential reference to detect cartilage anomaly.


2021 ◽  
Vol 23 (1) ◽  
Author(s):  
Dawn McGuire ◽  
Michael Bowes ◽  
Alan Brett ◽  
Neil A. Segal ◽  
Meghan Miller ◽  
...  

Abstract Background TPX-100, a promotor of osteoblast and chondroblast differentiation, is a potential osteoarthritis (OA) therapy. This retrospective study compared MRI 3D femoral bone shape changes (B-scores) after intra-articular TPX-100 or placebo and analyzed the relationship between cartilage thickness and bone shape change over 12 months. Methods One hundred and four participants with bilateral moderate to severe knee cartilage defects were randomized to receive TPX-100 (200 mg) or placebo. Each subject’s contralateral placebo-treated knee served as a paired internal control. After MRI quality control, 78/93 subjects (84%; 156 knees) were analyzed for quantitative femoral B-score and cartilage thickness. All analyses were performed centrally, blind to treatment assignment and clinical data. Results TPX-100-treated knees (n = 78) demonstrated a statistically significant decrease in pathologic bone shape change compared with placebo-treated knees at 6 and 12 months: 0.0298 (95% C.I. − 0.037, 0.097) vs 0.1246 (95% C.I. 0.067, 0.182) (P = 0.02), and 0.0856 (95% C.I. 0.013, 0.158) vs. 0.1969 (95% C.I. 0.123, 0.271) (P = 0.01), respectively. The correlation between bone shape change and medial and total tibiofemoral cartilage thickness changes at 12 months was statistically significant in TPX-100-treated knees (P < 0.01). Conclusions This is the first report of a potential therapy demonstrating a significant effect on bone shape measured by B-score in knee OA. These data, in combination with previously reported statistically significant and clinically meaningful improvements in WOMAC physical function versus placebo, support TPX-100 as a candidate for disease modification in knee OA. Trial registration NIH ClinicalTrials.gov, NCT01925261. Registered 15 August 2013


2021 ◽  
Author(s):  
Dawn McGuire ◽  
Michael Bowes ◽  
Alan Brett ◽  
Neil Segal ◽  
Meghan Miller ◽  
...  

Abstract Background: TPX-100, a promotor of osteoblast and chondroblast differentiation, is a potential osteoarthritis (OA) therapy. This retrospective study compared MRI 3D femoral bone shape changes (B-scores) after intra-articular TPX-100 or placebo and analyzed the relationship between cartilage thickness and bone shape change over 12 months.Methods: 104 participants with bilateral knee moderate to severe (ICRS 2-4) knee cartilage defects were randomized for evaluation of efficacy and safety of 200mg of TPX-100. Each subject’s contralateral placebo-treated knee served as a paired internal control. After MRI quality control, 78/93 subjects (84%; 156 knees) were analyzed for quantitative femoral B-score and cartilage thickness. All analyses were centrally performed, blind to treatment assignment and clinical data.Results: TPX-100-treated knees (n=78) demonstrated a statistically significant decrease in pathologic bone shape change compared with placebo-treated knees at 6 and 12 months: 0.0298 (95% C.I. -0.037, 0.097) vs 0.1246 (95% C.I. 0.067, 0.182) (P=0.02); and 0.0856 (95% C.I. 0.013, 0.158) vs. 0.1969 (95% C.I. 0.123, 0.271) (P = 0.01), respectively. The correlation between bone shape change and medial and total tibiofemoral cartilage thickness changes at 12 months was statistically significant in TPX-100-treated knees (P<0.01). Conclusions: This is the first report of a potential therapy demonstrating a significant effect on bone shape measured by B-score in knee OA. These data, in combination with previously reported statistically significant and clinically meaningful improvements in WOMAC function versus placebo, support TPX-100 as a candidate for disease modification in knee OA.Trial Registration: NIH clinicaltrials.gov, NCT01925261. Registered 15 August 2013, https://clinicaltrials.gov/ct2/show/NCT01925261?term=NCT01925261


Author(s):  
Aya Yassin ◽  
Maryam Ali Abdelkader ◽  
Rehab M. Mohammed ◽  
Ahmed M. Osman

Abstract Background Pulmonary embolism (PE) is one of the known sequels of COVID-19 infection. We aimed to assess the incidence of PE in patients with COVID-19 infection and to evaluate the relationship between the CT severity of the disease and the laboratory indicators. This was a retrospective study conducted on 96 patients with COVID-19 infection proved by positive PCR who underwent CT pulmonary angiography (CTPA) with a calculation of the CT severity of COVID-19 infection. Available patients’ complaint and laboratory data at the time of CTPA were correlated with PE presence and disease severity. Results Forty patients (41.7%) showed positive PE with the median time for the incidence of PE which was 12 days after onset of the disease. No significant correlation was found between the incidence of PE and the patients’ age, sex, laboratory results, and the CT severity of COVID-19. A statistically significant relation was found between the incidence of PE and the patients’ desaturation, hemoptysis, and chest pain. A highly significant correlation was found between the incidence of PE and the rising in the D-dimer level as well as the progressive CT findings when compared to the previous one. Conclusion CT progression and the rising in D-dimer level are considered the most important parameters suggesting underlying PE in patients with positive COVID-19 infection which is commonly seen during the second week of infection and alert the use of CT pulmonary angiography to exclude or confirm PE. This is may help in improving the management of COVID-19 infection.


2019 ◽  
Vol 55 (2) ◽  
pp. 81-87 ◽  
Author(s):  
Miguel Ángel Martinez-Garcia ◽  
Rodrigo Athanazio ◽  
Giorgina Gramblicka ◽  
Mónica Corso ◽  
Fernando Cavalcanti Lundgren ◽  
...  

2003 ◽  
Vol 93 (7) ◽  
pp. 790-798 ◽  
Author(s):  
Pablo H. Rosso ◽  
Everett M. Hansen

Swiss needle cast (SNC), caused by the fungus Phaeocryptopus gaeumannii, is producing extensive defoliation and growth reduction in Douglas-fir forest plantations along the Pacific Northwest coast. An SNC disease prediction model for the coastal area of Oregon was built by establishing the relationship between the distribution of disease and the environment. A ground-based disease survey (220 plots) was used to study this relationship. Two types of regression approaches, multiple linear regression and regression tree, were used to study the relationship between disease severity and climate, topography, soil, and forest stand characteristics. Fog occurrence, precipitation, temperature, elevation, and slope aspect were the variables that contributed to explain most of the variability in disease severity, as indicated by both the multiple regression (r 2 = 0.57) and regression tree (RMD = 0.27) analyses. The resulting regression model was used to construct a disease prediction map. Findings agree with and formalize our previous understanding of the ecology of SNC: warmer and wetter conditions, provided that summer temperatures are relatively low, appear to increase disease severity. Both regression approaches have characteristics that can be useful in helping to improve our understanding of the ecology of SNC. The prediction model is able to produce a continuous prediction surface, suitable for hypothesis testing and assisting in disease management and research.


Author(s):  
Furkan Kaya ◽  
Petek Şarlak Konya ◽  
Emin Demirel ◽  
Neşe Demirtürk ◽  
Semiha Orhan ◽  
...  

Background: Lungs are the primary organ of involvement of COVID-19, and the severity of pneumonia in COVID-19 patients is an important cause of morbidity and mortality. Aim: We aimed to evaluate the visual and quantitative pneumonia severity on chest computed tomography (CT) in patients with coronavirus disease 2019 (COVID-19) and compare the CT findings with clinical and laboratory findings. Methods: We retrospectively evaluated adult COVID-19 patients who underwent chest CT, clinical scores, laboratory findings, and length of hospital stay. Two independent radiologists visually evaluated the pneumonia severity on chest CT (VSQS). Quantitative CT (QCT) assessment was performed using a free DICOM viewer, and the percentage of the well-aerated lung (%WAL), high-attenuation areas (%HAA) at different threshold values, and mean lung attenuation (MLA) values were calculated. The relationship between CT scores and the clinical, laboratory data, and length of hospital stay were evaluated in this cross-sectional study. The student's t-test and chi-square test were used to analyze the differences between variables. The Pearson correlation test analyzed the correlation between variables. The diagnostic performance of the variables was assessed using receiver operating characteristic (ROC) analysis was used. Results: The VSQS and QCT scores were significantly correlated with procalcitonin, d-dimer, ferritin, and C-reactive protein levels. Both VSQ and QCT scores were significantly correlated with disease severity (p<0.001). Among the QCT parameters, the %HAA-600 value showed the best correlation with the VSQS (r=730,p<0.001). VSQS and QCT scores had high sensitivity and specificity in distinguishing disease severity and predicting prolonged hospitalization. Conclusion: The VSQS and QCT scores can help manage the COVID-19 and predict the duration of hospitalization.


Sign in / Sign up

Export Citation Format

Share Document